PCSK9: The Nexus of Lipoprotein Metabolism and Inflammation in COVID-19.

Goonewardena, Sascha N; Rosenson, Robert S

Goonewardena, Sascha N; Rosenson, Robert S.

Goonewardena SN; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: sngoonew@med.umich.edu.
Rosenson RS; Metabolism and Lipids Unit, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Icahn School of Medicine, New York, New York, USA.

J Am Coll Cardiol ; 81(3): 235-236, 2023 01 24.

Article in English | MEDLINE | ID: covidwho-2241065

Subject(s)

COVID-19; Proprotein Convertase 9; Humans; Inflammation; Lipoprotein(a); Receptors, LDL

Keywords

COVID-19; PCSK9; inflammation; lipoprotein

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proprotein Convertase 9 / COVID-19 Limits: Humans Language: English Journal: J Am Coll Cardiol Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google